Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom P Freeman

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
Psychopharmacology|September 17, 2021
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabisSam Craft, Jason A Ferris, Monica J Barratt, et al.
Frontiers in Psychiatry|January 7, 2021
Cannabis and COVID-19: Reasons for ConcernMargriet W van Laar, Pieter E Oomen, Charlotte J A van Miltenburg, et al.
Communications Medicine|July 19, 2025
Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescentsMartine Skumlien, Darcy Jones, Claire Mokrysz, et al.
The International Journal on Drug Policy|September 15, 2023
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome StudyJack Wilson, Katherine L Mills, Matthew Sunderland, et al.
The International Journal on Drug Policy|October 9, 2023
Synthetic cannabinoid use in an adult male prison in the UKSam Craft, Alice Austin, Tom Tooth, et al.
JAMA Psychiatry|May 28, 2020
Association of High-Potency Cannabis Use With Mental Health and Substance Use in AdolescenceLindsey A Hines, Tom P Freeman, Suzanne H Gage, et al.
Systematic Reviews|January 25, 2025
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysisJack Wilson, Andrew Langcake, Zachary Bryant, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2024
Acute effects of different types of cannabis on young adult and adolescent resting-state brain networksNatalie Ertl, Tom P Freeman, Claire Mokrysz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 26, 2026
The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controlsMartine Skumlien, Simiao Wang, Tom P Freeman, et al.
Addiction Biology|April 24, 2019
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzymeChandni Hindocha, Tom P Freeman, Grainne Schafer, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Psychopharmacology|September 17, 2021
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabisSam Craft, Jason A Ferris, Monica J Barratt, et al.
Frontiers in Psychiatry|January 7, 2021
Cannabis and COVID-19: Reasons for ConcernMargriet W van Laar, Pieter E Oomen, Charlotte J A van Miltenburg, et al.
Communications Medicine|July 19, 2025
Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescentsMartine Skumlien, Darcy Jones, Claire Mokrysz, et al.
The International Journal on Drug Policy|September 15, 2023
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome StudyJack Wilson, Katherine L Mills, Matthew Sunderland, et al.
The International Journal on Drug Policy|October 9, 2023
Synthetic cannabinoid use in an adult male prison in the UKSam Craft, Alice Austin, Tom Tooth, et al.
JAMA Psychiatry|May 28, 2020
Association of High-Potency Cannabis Use With Mental Health and Substance Use in AdolescenceLindsey A Hines, Tom P Freeman, Suzanne H Gage, et al.
Systematic Reviews|January 25, 2025
The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysisJack Wilson, Andrew Langcake, Zachary Bryant, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 28, 2024
Acute effects of different types of cannabis on young adult and adolescent resting-state brain networksNatalie Ertl, Tom P Freeman, Claire Mokrysz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 26, 2026
The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controlsMartine Skumlien, Simiao Wang, Tom P Freeman, et al.
Addiction Biology|April 24, 2019
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzymeChandni Hindocha, Tom P Freeman, Grainne Schafer, et al.
Pageof 20